发明名称 Pharmaceutical agents
摘要 This invention relates to compounds of formula (1) wherein B is optionally substituted aryl; R<SUP>1 </SUP>and R<SUP>2 </SUP>are the same or different and are independently selected from hydrogen or C<SUB>1-3 </SUB>alkyl; n is 1 or 2, preferably n is 1; m is 0 or 1; R<SUP>3 </SUP>is hydrogen or acyl; R<SUP>4 </SUP>and R<SUP>5 </SUP>are the same or different and are independently selected from amino, alkylamino, dialkylamino, arylamino and C<SUB>2</SUB>-C<SUB>8 </SUB>cycloalkylamino; X and Y are independently selected from C, H or N provided at least one of X and Y is N; and salts thereof, solvates thereof, pharmaceutically acceptable derivatives thereof, prodrugs thereof, tautomers thereof and/or isomers thereof; and processes for their preparation and methods of treatment, pharmaceutical formulations and uses involving them.
申请公布号 AU4762599(A) 申请公布日期 2000.02.01
申请号 AU19990047625 申请日期 1999.07.08
申请人 MONASH UNIVERSITY 发明人 BEVYN JARROTT;PHILLIP MARK BEART;WILLIAM ROY JACKSON;ALAN DUNCAN ROBERTSON;MAREE PATRICIA COLLIS;ALEXANDRA PAPANIKOS
分类号 C07D251/48;A61K31/505;A61K31/506;A61K31/53;A61P1/08;A61P9/02;A61P9/10;A61P9/12;A61P11/06;A61P13/10;A61P25/00;A61P25/02;A61P25/04;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P43/00;C07D239/48;C07D239/49;C07D239/50;C07D251/70;C07D401/06;C07D401/12;C07D403/06;C07D403/12;C07D405/06;C07D405/12;C07D409/06;C07D409/12;C07D417/06;C07D417/12 主分类号 C07D251/48
代理机构 代理人
主权项
地址